August 11, 2020

Volume X, Number 224

August 11, 2020

Subscribe to Latest Legal News and Analysis

August 10, 2020

Subscribe to Latest Legal News and Analysis

Healthcare Extenders: What’s on the Table for 2019

We have 20 scheduled joint legislative days left until the current continuing resolution funding the government ends on November 21, 2019, followed by an additional eight scheduled joint legislative days until the end of the year. These are significant dates for several important healthcare programs that either run out of funding or face dramatic cuts to existing funding on November 21 or December 31, 2019. One key to understanding how Congress will tackle these challenges is the costs associated with any extension or delay of cuts.

Due to the varying scope of these issues, a number of congressional committees are working on legislation to extend these programs. As a result, it is a complicated dance to get these programs extended and also funded. Although political divisions in Washington, DC, are at an all-time high, we still expect that many of the expiring programs will be extended by year-end. In fact, some of the expiring provisions were extended in the last continuing resolution (CR) through November 21, 2019. Currently Congress is working to address the expiring provisions prior to November 21, 2019, to avoid a lapse in funding. The questions remain how long each program will be extended and how they will be paid for. The below chart provides a summary of each of the major healthcare extender provisions, current financial status, expiration date and proposals for extension.

Background: Healthcare extenders typically refer to the various temporary policies that require continual reauthorization or annual appropriations. These include community health center funding, teaching health center funding and special diabetes programs. Additionally, healthcare extenders include several Affordable Care Act (ACA) policies whose implementation has been delayed, such as the Medicaid Disproportionate Share Hospital (DSH) allotment reduction, the ACA health insurance tax and the medical device tax.

Click here for the chart summary.

© 2020 McDermott Will & EmeryNational Law Review, Volume IX, Number 284


About this Author

Rachel Stauffer, McDermott Law Firm, Washington DC, Health Policy Consultant

Rachel is a highly experienced government relations and legislative affairs strategist and advocate who is informed by a solid foundation of health policy knowledge.

Prior to joining McDermottPlus, Rachel served as the director of policy and government relations for a health IT contractor, where she developed the company’s first strategic plan for government relations. She grew the company’s profile on Capitol Hill by establishing new relationships with key leaders in the federal, state and military health program space. As a result, the company...

Katie Waldo Healthcare Attorney

Katie is an experienced government relations strategist who helps clients navigate the complex issues surrounding Medicare, Medicaid and the healthcare marketplace.

Katie works with clients to represent their needs before the US Congress and the US Department of Health and Human Services (HHS) and its agencies by relying on extensive experience as a policy advisor on the Medicaid and Medicare programs, as well as the 340B program and other aspects of the Public Health Service Act. She anticipates the effects of state and federal policymaking on issues impacting their businesses and crafts proactive and comprehensive legislative strategies.

Katie served as a senior analyst at the Medicaid and CHIP Payment and Access Commission (MACPAC), where she developed policy recommendations and conducted legislative analyses related to Medicare and Medicaid issues in support of Congress and HHS. At MACPAC, Katie regularly interpreted and analyzed large data sets for reports.

Prior to her work with MACPAC, Katie served in Senator Chuck Grassley’s (R-IA) office as a health policy fellow where she conducted research and analyses on health policy options. She also worked at the George Washington University, where she led the Teaching Health Center Graduate Medical Education evaluation.

212 547 5433
Government Relations Professional and Registered Lobbyist

Emma is a government relations professional and registered lobbyist who supports clients on a range of health policy issues.

As a policy consultant, Emma lobbies and consults with legislators and congressional staff on issues relating to Medicare, Medicaid payment and regulation, and the 340B Drug Pricing Program. She provides analysis of the federal political and regulatory environment, and routinely monitors pertinent Hill activities including congressional hearings, bill markups and think tank events.

Emma graduated...